(Q29619799)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

Telaprevir for Retreatment of HCV Infection (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

5 December 2024

10

Horban A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

author name string

Stefan Zeuzem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Pietro Andreone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Stanislas Pol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Eric Lawitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Moises Diago

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Stuart Roberts

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Roberto Focaccia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Zobair Younossi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Graham R. Foster

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Peter Ferenci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Frederik Nevens

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Beat Müllhaupt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Paul Pockros

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Ruben Terg

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Daniel Shouval

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Bart van Hoek

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Ola Weiland

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Rolf Van Heeswijk

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Sandra De Meyer

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Don Luo

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Griet Boogaerts

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Ramon Polo

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Gaston Picchio

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

Maria Beumont

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

5 December 2024

REALIZE Study Team

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21696308

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

5 December 2024

language of work or name

1 reference

30 April 2017

publication date

23 June 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

The New England Journal of Medicine

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

volume

364

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

issue

25

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

page(s)

2417-28

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

30 April 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

5 December 2024

2

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Telaprevir for previously treated chronic HCV infection

5 December 2024

3

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

5 December 2024

5

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Boceprevir for previously treated chronic HCV genotype 1 infection

5 December 2024

7

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

5 December 2024

8

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

5 December 2024

9

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

5 December 2024

10

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Resistance to direct antiviral agents in patients with hepatitis C virus infection

5 December 2024

11

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

5 December 2024

12

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

5 December 2024

13

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

5 December 2024

14

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Genetic variations in heme oxygenase-1 and chronic hepatitis

5 December 2024

15

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

5 December 2024

16

1 reference

https://api.crossref.org/works/10.1056/NEJMOA1013086

5 December 2024

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21696308

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

363175

Fatcat ID

release_77iwcrgdjfe2zljistfjek55va

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/77iwcrgdjfe2zljistfjek55va

mapped directly with Wikidata item

24 November 2022

based on heuristic

OpenCitations bibliographic resource ID

363175

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

363175